Campbell & CO Investment Adviser LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 112 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$273,267
-47.4%
10,030
-57.0%
0.03%
-64.5%
Q2 2023$519,538
+23.4%
23,350
+20.1%
0.09%
+19.2%
Q1 2023$421,070
-67.7%
19,440
-69.7%
0.08%
-75.0%
Q4 2022$1,302,440
+37.5%
64,128
+73.7%
0.31%
+45.1%
Q3 2022$947,000
+109.1%
36,917
+93.9%
0.22%
+76.2%
Q2 2022$453,000
-62.4%
19,042
-64.4%
0.12%
-62.5%
Q1 2022$1,205,000
+277.7%
53,500
+230.2%
0.32%
+212.5%
Q3 2021$319,000
-0.9%
16,200
+10.6%
0.10%
-21.8%
Q2 2021$322,000
+15.8%
14,650
+25.2%
0.13%
-22.2%
Q1 2021$278,000
-45.8%
11,700
-60.3%
0.17%
-55.2%
Q3 2020$513,000
-34.3%
29,487
-54.3%
0.38%
+59.8%
Q4 2019$781,000
+73.6%
64,508
+176.9%
0.24%
-34.3%
Q3 2017$450,000
+163.2%
23,300
+60.4%
0.36%
+128.9%
Q2 2017$171,000
+6.9%
14,530
-0.6%
0.16%
-61.6%
Q1 2017$160,000
+36.8%
14,613
-9.3%
0.41%
+14.7%
Q4 2016$117,000
-15.8%
16,111
-24.9%
0.36%
-3.5%
Q3 2016$139,000
+61.6%
21,446
+35.8%
0.37%
-14.0%
Q2 2016$86,00015,7940.44%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,951,077$178,226,0009.95%
Parallel Advisors, LLC 3,769,455$96,649,0004.45%
Novo Holdings A/S 3,327,768$85,324,0004.07%
TANAKA CAPITAL MANAGEMENT INC 35,539$911,0002.72%
Quantedge Capital Pte Ltd 243,712$6,249,0001.93%
S&T BANK/PA 349,456$8,960,0001.73%
Birchview Capital, LP 50,000$1,282,0000.90%
Bridge City Capital, LLC 61,254$1,571,0000.86%
FAS Wealth Partners, Inc. 299,576$7,681,0000.85%
AJ WEALTH STRATEGIES, LLC 509,934$13,075,0000.76%
View complete list of CORCEPT THERAPEUTICS INC shareholders